Cash-strapped Zoono seeks A$2.1m from rights issue

Cash-strapped Zoono seeks A$2.1m from rights issue
Hand and surface sanitisers were in demand during the pandemic. (Image: Getty)
Denise McNabb
After continuing to burn cash and as its revenue plunges, Zoono Group plans to raise A$2.1 million (NZ$2.2m) through a pro-rata rights issue with free options to fund projects, a joint venture with Douglas Pharmaceuticals, China expansion and working capital. The Australian stock exchange-listed New Zealand manufacturer of antimicrobial hand and surface sanitisers announced the share offer in tandem with the release of its March 31 third-quarter report.The report details a dire future for the company unless it changes direction away from e...

More Markets

The ‘Aussie Premium’ baked into NZX stocks
Opinion

Brian Robins: The ‘Aussie Premium’ baked into NZX stocks

New Zealand entities launching in Australia have clear benefits.

An updated recap: Fonterra’s $4.2b Mainland sale
Primary Sector

An updated recap: Fonterra’s $4.2b Mainland sale

Today's the day the sale will get the blessing of farmers.

Locate Technologies posts quarterly loss ahead of NZX listing move
Markets

Locate Technologies posts quarterly loss ahead of NZX listing move

Locate will be providing New Zealand’s first listed bitcoin treasury.